v3.26.3
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 9 Months Ended
Sep. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The Company records all cash flow hedging instruments on the consolidated balance sheets at fair value. The fair values of outstanding derivative instruments designated as cash flow hedging instruments were as follows:
September 30,
December 31,
20262025
Unaudited
Prepaid expenses and other current assets$629 $534 
Accrued expenses and other current liabilities$(884)$— 
Schedule of Derivative Instruments, Gain (Loss)
The gains related to cash flow hedging instruments, recorded in the consolidated interim statements of income (loss), for the three and nine months ended September 30, 2026 and 2025, were as follows:
Three months ended September 30,Nine months ended
September 30,
2026202520262025
Unaudited
Cost of revenues$28 $124 $205 $207 
Research and development254 1,105 1,879 1,830 
Sales and marketing56 288 425 476 
General and administrative45 205 344 341 
Total gains recognized in the consolidated statements of income (loss), net$383 $1,722 $2,853 $2,854 
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)
The changes in unrealized gains (losses) on the Company’s derivative instruments recorded in accumulated other comprehensive income (loss) were as follows:
Nine months ended
September 30,
20262025
Unaudited
Unrealized gains on derivative instruments at the beginning of the period$534 $418 
Changes in fair value of derivative instruments1,950 3,929 
Reclassification of gains recognized in the consolidated statements of income (loss) from accumulated other comprehensive income (loss)(2,853)(2,854)
Unrealized gains (losses) on derivative instruments at the end of the period (unaudited)$(369)$1,493